MA29852B1 - Synthese d'inhibiteurs de la renine impliquant une reaction de cycloaddition - Google Patents

Synthese d'inhibiteurs de la renine impliquant une reaction de cycloaddition

Info

Publication number
MA29852B1
MA29852B1 MA30815A MA30815A MA29852B1 MA 29852 B1 MA29852 B1 MA 29852B1 MA 30815 A MA30815 A MA 30815A MA 30815 A MA30815 A MA 30815A MA 29852 B1 MA29852 B1 MA 29852B1
Authority
MA
Morocco
Prior art keywords
synthesis
cycloaddition reaction
renine
formula
inhibitors involving
Prior art date
Application number
MA30815A
Other languages
English (en)
Inventor
Stuart John Mickel
Wolfgang Marterer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35394904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29852(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA29852B1 publication Critical patent/MA29852B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

L'invention concerne un nouveau procédé, de nouvelles étapes de processus ainsi que de nouveaux intermédiaires utilisés dans la synthèse de composés actif sur le plan pharmaceutique, en particulier des inhibiteurs de la rénine, tels que l'aliskiren. L'invention concerne notamment un procédé de préparation d'un composé représenté par la formule (III), dans laquelle R, R1, et R¿ sont tels que définis dans la description, ou un sel de celui-ci, un composé représenté par la formule (IV), dans laquelle R, R1, R2 et R' sont tels que définis dans la description, ainsi que des procédés de fabrication de ces composés.
MA30815A 2005-09-28 2008-04-04 Synthese d'inhibiteurs de la renine impliquant une reaction de cycloaddition MA29852B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0519764.5A GB0519764D0 (en) 2005-09-28 2005-09-28 Organic compounds

Publications (1)

Publication Number Publication Date
MA29852B1 true MA29852B1 (fr) 2008-10-03

Family

ID=35394904

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30815A MA29852B1 (fr) 2005-09-28 2008-04-04 Synthese d'inhibiteurs de la renine impliquant une reaction de cycloaddition

Country Status (27)

Country Link
US (2) US7973175B2 (fr)
EP (2) EP1931629B1 (fr)
JP (1) JP2009509990A (fr)
KR (1) KR20080048042A (fr)
CN (1) CN101273012A (fr)
AR (1) AR057137A1 (fr)
AT (1) ATE492533T1 (fr)
AU (1) AU2006299097B2 (fr)
BR (1) BRPI0616707A2 (fr)
CA (1) CA2623495A1 (fr)
DE (1) DE602006019114D1 (fr)
EC (1) ECSP088319A (fr)
ES (1) ES2358536T3 (fr)
GB (1) GB0519764D0 (fr)
GT (1) GT200600427A (fr)
IL (1) IL189763A0 (fr)
MA (1) MA29852B1 (fr)
MY (1) MY143251A (fr)
NO (1) NO20082005L (fr)
NZ (1) NZ566429A (fr)
PE (1) PE20070488A1 (fr)
PL (1) PL1931629T3 (fr)
PT (1) PT1931629E (fr)
RU (1) RU2423348C2 (fr)
TN (1) TNSN08142A1 (fr)
TW (1) TW200730480A (fr)
WO (1) WO2007039183A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062874B1 (fr) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Procédé et intermédiaires pour la préparation d'aliskiren
SI2189442T1 (sl) 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
WO2011051853A1 (fr) 2009-10-29 2011-05-05 CarboDesign LLC Procédé de production de dérivés d'acides 8-aryloctanoïques énantiomèrement purs tels que l'aliskiren
CN101774986B (zh) * 2010-01-06 2012-03-28 浙江天宇药业股份有限公司 一种制备阿利克伦及其中间体的方法
CN101863796B (zh) * 2010-05-12 2011-08-24 海南美兰史克制药有限公司 一种阿利克仑化合物及其制法
EP2551260A1 (fr) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Procédé chimique pour l'ouverture de composés cycliques
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421295A1 (de) 1984-06-08 1985-12-12 Basf Ag, 6700 Ludwigshafen Neue pyrrolidincarbonsaeurederivative, verfahren zu ihrer herstellung
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US6730798B2 (en) 2000-07-05 2004-05-04 Speedel Pharma Ag Process for the preparation of substituted octanoyl amides
DE10116816A1 (de) * 2001-04-04 2002-10-17 Basf Ag Verfahren zur Herstellung von N-Benzylaminen
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
NO20082005L (no) 2008-06-24
PE20070488A1 (es) 2007-06-13
TNSN08142A1 (en) 2009-07-14
AR057137A1 (es) 2007-11-21
EP1931629A1 (fr) 2008-06-18
JP2009509990A (ja) 2009-03-12
US7973175B2 (en) 2011-07-05
RU2008116317A (ru) 2009-11-10
IL189763A0 (en) 2008-08-07
AU2006299097B2 (en) 2010-11-04
ES2358536T3 (es) 2011-05-11
GB0519764D0 (en) 2005-11-09
ATE492533T1 (de) 2011-01-15
WO2007039183A1 (fr) 2007-04-12
ECSP088319A (es) 2008-04-28
NZ566429A (en) 2010-10-29
MY143251A (en) 2011-04-15
PT1931629E (pt) 2011-03-09
GT200600427A (es) 2007-04-30
EP2287153A1 (fr) 2011-02-23
US20080255369A1 (en) 2008-10-16
DE602006019114D1 (de) 2011-02-03
CA2623495A1 (fr) 2007-04-12
PL1931629T3 (pl) 2011-05-31
BRPI0616707A2 (pt) 2011-06-28
US20110230665A1 (en) 2011-09-22
EP1931629B1 (fr) 2010-12-22
RU2423348C2 (ru) 2011-07-10
KR20080048042A (ko) 2008-05-30
CN101273012A (zh) 2008-09-24
AU2006299097A1 (en) 2007-04-12
TW200730480A (en) 2007-08-16

Similar Documents

Publication Publication Date Title
MA33636B1 (fr) Dérivés aminopropioniques substitués comme inhibiteurs de néprilysine
MA29620B1 (fr) Nouveau derive de 1,4-benzothiazepine-1,1-dioxyde presentant des proprietes ameliorees, procede pour sa preparation, medicaments contenant ce compose, et son utilisation
MA27660A1 (fr) Derive heteroarylcarbamoylbenzene
MA31325B1 (fr) Nouveaux procedes
TNSN08270A1 (fr) Dérivés pyrimidiques destinés à traiter une croissance cellulaire anormale
MA32089B1 (fr) Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
DE60205241D1 (de) Synthese von cannabinoiden
MA29563B1 (fr) Composes organiques
EP2638007A2 (fr) Dérivés de médicaments
TN2009000428A1 (fr) Derives de sulfonylamides destines au traitement d'une croissance cellulaire anormale
MA30724B1 (fr) Procede de preparation d'acide 4-amino-butyrique substitue par biaryle ou de derives de celui-ci et leur utilisation pour produire des inhibiteurs de nep.
TNSN08170A1 (en) 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
MA29311B1 (fr) Derives d'isoxazolines et son nouveau procede de production
MA31116B1 (fr) Procede de synthese de derives de l'acide 3-amino-tetrahydro-furan-3-carboxylique et utilisation de ceux-ci en tant que medicaments
MA35133B1 (fr) Dérivés d'éthynyle comme modulateurs allostériques positifs de mglur5
JP2022521106A (ja) 高エナンチオ選択性第2級アルコールを作製する方法
MA31926B1 (fr) Procédé pour la préparation de 1-(2h)-isoquinoléinones 6-substituées
TNSN08142A1 (en) Synthesis of renin inhibitors involving a cycloaddition reaction
CA2494024A1 (fr) Nouveaux promedicaments de 1-methyl-2(4-amidinophenylaminomethyl)-benzimidazol-5-yl-acide carboxylique-(n-2-pyridil-n-2-hydroxycarbonylethyl)-amide, leur preparation et leur utilisation en tant que medicaments
MA27517A1 (fr) Nouveau procede de synthese du (7-methoxy-1-naphtyl)acetonitrile et application a la synthese de l'agomelatine
MA27515A1 (fr) Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl)acetonitrile et application a la synthese de l'agomelatine
NZ544004A (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
Panigrahi Ultrasound assisted synthesis, characterization and antimicrobial evaluation of novel oxazolidinone-biphenyl chalcone hybrid derivatives
JPWO2009063804A1 (ja) N−カルバモイル−tert−ロイシンの製造法
BRPI0516192A (pt) composto, e, método para a preparação de um composto